FPH Announces New Future Director Appointment

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare Announces New Future Director Appointment
Auckland, New Zealand, 30 May 2022 – Fisher & Paykel Healthcare Corporation Limited announced
today that it has selected Tracey Barron to participate in the Future Directors programme, with effect
from 1 June 2022.
Ms Barron has more than 25 years of experience across a broad range of health-related roles. This
includes working for the Southern Cross Group in a range of capacities, including most recently as
Chief of Strategy for Southern Cross Healthcare. Ms Barron has previously also held management
roles with the Counties Manukau District Health Board, the Ministry of Health and Pharmac, and has
been a director of a number of health care businesses.
She received a master of science in clinical pharmacy from Derby University in the United Kingdom
and an MBA from Massey University.
Future Directors is an initiative of the Institute of Directors aimed at giving talented executives
exposure to a company board for a 12- to 18-month period in order to develop governance
experience. Future Directors attend board meetings to observe and participate in discussions, but
they do not have voting rights.
“We welcome the perspective and experience that Tracey will bring,” said Scott St John, Board
Chair. “She is a proven executive with a deep understanding of public and private health systems.
I’m looking forward to her contribution.”
Ms Barron said, “I am grateful for the opportunity to be a Future Director for Fisher & Paykel
Healthcare – an innovative and successful company with a global reputation and reach. I’m looking
forward to learning from the Board, developing my governance skills and contributing from my own
experience.”
Fis her & Paykel Healthcare’s previo us Fut ure Director, Toni Moyes, has now completed her term
with the company.
“We see the Future Directors’ programme as a win-win,” said Mr St John. “It brings a fresh voice to
the boardroom while providing t he next generation of directors with a chance to hone their
governance skills. We are pleased to continue supporting it.”
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems f or use in acute and chronic respiratory care, surgery and t he treatment of obstructive sleep
apnea. The company’s products are sol d in over 120 countries worldwide. For more information
about the company, visit our website www.fphcare.com.
ENDS
Media & Investor Contacts:
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board Chair.